#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage II Mastocytosis Type IIa hyperlipidaemia Arrhythmia Gastroenteropancreatic neuroendocrine tumour disease Barth syndrome Retinopathy of prematurity Stevens-Johnson syndrome NTRK gene fusion overexpression Short stature homeobox gene mutation Anaplastic large cell lymphoma T- and null-cell types Warm autoimmune haemolytic anaemia Raynaud's phenomenon Congenital nephrogenic diabetes insipidus Mucopolysaccharidosis I More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Treatment Synovial sarcoma recurrent – Basic Information Waldenstrom’s macroglobulinaemia Hepatic angiosarcoma – Treatment Vascular malformation – Treatment Metachromatic leukodystrophy – Treatment Gaucher’s disease type I – Life with Disease Metachromatic leukodystrophy – Trials in Disease Mantle cell lymphoma stage II – Trials in Disease Langerhans’ cell histiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    20-HYDROXYECDYSONE Dotatate Asciminib Aldesleukin Eletriptan Benralizumab Zolbetuximab Tiotropium Bromide Monohydrate Ondansetron Hydrochloride Cannabidiol Isis 696844 Olopatadine Omp10 Etelcalcetide Naltrexone Hydrochloride Glipizide Etrasimod Arginine Plerixafor Flucloxacillin Pamiparib More therapies…

    Learn about Your Condition

    Malignant peritoneal neoplasm Cutibacterium acnes infection Acute respiratory failure Marfan's syndrome Spina bifida Deafness bilateral Peritonitis Endocrine disorder Follicular lymphoma Biliary tract operation Bacterial prostatitis Pneumococcal infection Endocarditis Muscle hypertrophy Acute leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

  • Study on the Effectiveness and Safety of CR9114 for Preventing Influenza in Healthy Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • WILD-TYPE A INFLUENZA VIRUS A/BELGIUM/4217/2015 (H3N2)
    Belgium

  • Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Vosoritide
    Germany Spain

  • Study on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypoparathyroidism
    Investigated Drugs:
    • Alfacalcidol
    • Calcitriol
    • Calcium Carbonate
    Belgium Denmark France Germany Hungary Italy +4

  • Efficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial

    Not recruiting

    4 1
    Investigated Drugs:
    • Tulisokibart
    France Germany Italy The Netherlands Spain

  • A study to test if tibulizumab works and is safe for adults with systemic sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Hungary Poland Romania Spain
Previous Page
1 … 1,631 1,632 1,633 1,634 1,635 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!